Ladrx and Immunitybio mutually agree to terminate the Aldoxorubicin license.
Ladrx和Immunitybio相互同意终止Aldoxorubicin许可证。
Ladrx and Immunitybio mutually agree to terminate the Aldoxorubicin license.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated